BROMOCRIPTINE AND LEVODOPA (WITH OR WITHOUT CARBIDOPA) IN PARKINSONISM
- 1 August 1976
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 308 (7980), 272-275
- https://doi.org/10.1016/s0140-6736(76)90728-5
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Studies with bromocriptine Part 2. Double‐blind comparison with levodopa in idiopathic parkinsonismNeurology, 1976
- Treatment of Parkinson's Disease with AporphinesNew England Journal of Medicine, 1976
- IDIOPATHIC PARKINSONISM TREATED WITH BROMOCREPTINEThe Lancet, 1975
- TREATMENT OF PARKINSONISM WITH BROMOCRIPTINEThe Lancet, 1974
- Bromocriptine in ParkinsonismBMJ, 1974
- Long-lasting anti-tremor activity induced by 2-Br-α-ergocryptine in monkeysJournal of Pharmacy and Pharmacology, 1974
- Effect of ergot drugs on central catecholamine neurons: Evidence for a stimulation of central dopamine neuronsJournal of Pharmacy and Pharmacology, 1973
- THE INHIBITION OF PROLACTIN SECRETION IN MAN BY CB-154 (2-Br-α-ergocryptine)Journal of Clinical Endocrinology & Metabolism, 1972
- Suppression of Puerperal Lactation with an Ergot Alkaloid: A Double-blind StudyBMJ, 1972
- Parkinson's Disease: Activity of L-Dopa Decarboxylase in Discrete Brain RegionsScience, 1970